ATE407700T1 - Veränderung der mikrobenflora im verdauungstrakt - Google Patents

Veränderung der mikrobenflora im verdauungstrakt

Info

Publication number
ATE407700T1
ATE407700T1 AT97908076T AT97908076T ATE407700T1 AT E407700 T1 ATE407700 T1 AT E407700T1 AT 97908076 T AT97908076 T AT 97908076T AT 97908076 T AT97908076 T AT 97908076T AT E407700 T1 ATE407700 T1 AT E407700T1
Authority
AT
Austria
Prior art keywords
microogranisms
microbian
flora
change
digestive tract
Prior art date
Application number
AT97908076T
Other languages
English (en)
Inventor
Ian Brown
Patricia Conway
Anthony Evans
Karl Henriksson
Kenneth Mcnaught
Xin Wang
Original Assignee
Univ New South Wales
Burns Philp & Company Ltd
Burns Philp Res & Dev Pty Ltd
Commw Scient Ind Res Org
Arnott S Biscuits Ltd
Gist Brocades Australia Pty Lt
Goodman Fielder Ingredients Lt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPN8811A external-priority patent/AUPN881196A0/en
Priority claimed from AUPN8812A external-priority patent/AUPN881296A0/en
Priority claimed from AUPN8810A external-priority patent/AUPN881096A0/en
Priority claimed from AUPN8814A external-priority patent/AUPN881496A0/en
Application filed by Univ New South Wales, Burns Philp & Company Ltd, Burns Philp Res & Dev Pty Ltd, Commw Scient Ind Res Org, Arnott S Biscuits Ltd, Gist Brocades Australia Pty Lt, Goodman Fielder Ingredients Lt filed Critical Univ New South Wales
Application granted granted Critical
Publication of ATE407700T1 publication Critical patent/ATE407700T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/212—Starch; Modified starch; Starch derivatives, e.g. esters or ethers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/212—Starch; Modified starch; Starch derivatives, e.g. esters or ethers
    • A23L29/219—Chemically modified starch; Reaction or complexation products of starch with other chemicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT97908076T 1996-03-20 1997-03-20 Veränderung der mikrobenflora im verdauungstrakt ATE407700T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPN8811A AUPN881196A0 (en) 1996-03-20 1996-03-20 Alteration of microbial populations in the gastrointestinal tract
AUPN8812A AUPN881296A0 (en) 1996-03-20 1996-03-20 Elevation of short chain fatty acids in the gastrointestinal tract
AUPN8810A AUPN881096A0 (en) 1996-03-20 1996-03-20 Method of suppressing microbial pathogens
AUPN8814A AUPN881496A0 (en) 1996-03-20 1996-03-20 Attachment of bacteria to starches

Publications (1)

Publication Number Publication Date
ATE407700T1 true ATE407700T1 (de) 2008-09-15

Family

ID=27424409

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97908076T ATE407700T1 (de) 1996-03-20 1997-03-20 Veränderung der mikrobenflora im verdauungstrakt

Country Status (8)

Country Link
US (2) US6348452B1 (de)
EP (1) EP0901371B1 (de)
JP (1) JP4282763B2 (de)
KR (1) KR20000064729A (de)
AT (1) ATE407700T1 (de)
CA (1) CA2249189A1 (de)
DE (1) DE69738975D1 (de)
WO (1) WO1997034591A1 (de)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO824397A0 (en) * 1997-07-25 1997-08-21 Arnott's Biscuits Limited Improved food products
AUPP816899A0 (en) * 1999-01-14 1999-02-11 Food Technology Innovations Pty Limited Improved microbial products
FR2808689B1 (fr) * 2000-05-11 2004-09-03 Agronomique Inst Nat Rech Utilisation de souches acetogenes hydrogenotrophes pour la prevention ou le traitement de troubles digestifs
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
US20050123583A1 (en) * 2000-12-18 2005-06-09 Hsing-Wen Sung Medical use of reuterin
KR100485155B1 (ko) * 2002-05-22 2005-04-22 주식회사 삼양제넥스 효소저항전분을 포함하는 면역활성 증강용 조성물
IL152127A0 (en) * 2002-10-06 2003-05-29 Bio Balance Corp Probiotic compositions for the treatment of inflammatory bowel disease
WO2004043140A2 (en) * 2002-11-07 2004-05-27 Advanced Bionutrition Corp. Nutraceuticals and method of feeding aquatic animals
US7252836B2 (en) * 2003-01-13 2007-08-07 Penwest, Ltd. Food and feed compositions including resistant starch
JP4923171B2 (ja) 2003-06-30 2012-04-25 コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガニゼイション 分枝酵素の活性を改変した小麦、ならびにそれから得たデンプンおよびデンプン含有品
US20060093592A1 (en) * 2004-10-04 2006-05-04 Nutracea Synbiotics
US7189288B2 (en) * 2004-10-08 2007-03-13 Tate & Lyle Ingredients Americas, Inc. Enzyme-resistant starch and method for its production
AU2011202664B2 (en) * 2004-12-08 2012-04-05 Cedars-Sinai Medical Center Methods for diagnosis and treatment of Crohn's disease
US10544459B2 (en) 2004-12-08 2020-01-28 Cedars-Sinai Medical Center Methods of using genetic variants for the diagnosis and treatment of inflammatory bowel disease
US11268149B2 (en) 2004-12-08 2022-03-08 Cedars-Sinai Medical Center Diagnosis and treatment of inflammatory bowel disease
US12110555B2 (en) 2004-12-08 2024-10-08 Cedars-Sinai Medical Center Diagnosis and treatment of inflammatory bowel disease
US7700139B2 (en) 2004-12-30 2010-04-20 Commonwealth Scientific And Industrial Research Organization Method and means for improving bowel health
WO2006069422A1 (en) * 2004-12-30 2006-07-06 Commonwealth Scientific And Industrial Research Organisation Method and means for improving bowel health
US7276126B2 (en) * 2005-06-03 2007-10-02 Tate And Lyle Ingredients Americas, Inc. Production of enzyme-resistant starch by extrusion
US7674897B2 (en) 2005-09-09 2010-03-09 Tate & Lyle Ingredients Americas, Inc. Production of crystalline short chain amylose
WO2007084500A2 (en) * 2006-01-13 2007-07-26 Advanced Bionutrition Corporation Continuous spray-capture production system
US8057840B2 (en) * 2006-01-25 2011-11-15 Tate & Lyle Ingredients Americas Llc Food products comprising a slowly digestible or digestion resistant carbohydrate composition
US7608436B2 (en) * 2006-01-25 2009-10-27 Tate & Lyle Ingredients Americas, Inc. Process for producing saccharide oligomers
US8993039B2 (en) 2006-01-25 2015-03-31 Tate & Lyle Ingredients Americas Llc Fiber-containing carbohydrate composition
US20080069861A1 (en) * 2006-09-19 2008-03-20 National Starch And Chemical Investment Holding Corporation Probiotic/Non-Probiotic Combinations
DE102006062250A1 (de) * 2006-12-22 2008-06-26 Roland Saur-Brosch Verwendung einer Zusammensetzung aus Mineralstoffen und/oder Vitaminen und gegebenenfalls acetogenen und/oder butyrogenen Bakterien zur oralen oder rektalen Verabreichung für die Behandlung und Vorbeugung von abdominalen Beschwerden
WO2010036876A2 (en) 2008-09-25 2010-04-01 New York University Compositions and methods for characterizing and restoring gastrointestinal, skin, and nasal microbiota
JP2010047606A (ja) * 2009-11-25 2010-03-04 Kao Corp 便秘改善剤
NZ600258A (en) 2009-12-22 2014-01-31 Probi Ab Non-fermented compositions comprising a cereal based fraction and a probiotic and uses thereof
WO2011151941A1 (ja) * 2010-06-04 2011-12-08 国立大学法人東京大学 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
US9386793B2 (en) * 2010-08-20 2016-07-12 New York University Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
JP5905032B2 (ja) * 2011-02-09 2016-04-20 ラヴィヴォ・アーベー 腸管内微生物叢の回復および再構成のためのシンバイオティクス組成物
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
CN104160014A (zh) 2011-12-01 2014-11-19 国立大学法人东京大学 诱导调节性t细胞的增殖或积累的人源细菌
GB201212588D0 (en) * 2012-07-13 2012-08-29 Univ Glasgow Colicins for treating bacterial infections
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
JP6271093B1 (ja) 2014-12-23 2018-01-31 フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ 免疫調節
ES2668934T3 (es) 2014-12-23 2018-05-23 4D Pharma Research Limited Polipéptido pirin y modulación inmune
PE20180267A1 (es) 2015-06-15 2018-02-06 4D Pharma Res Ltd Composiciones que comprenden cepas bacterianas
NZ777234A (en) 2015-06-15 2022-02-25 4D Pharma Res Ltd Compositions comprising bacterial strains
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
PE20180243A1 (es) 2015-06-15 2018-01-31 4D Pharma Res Ltd Composiciones que comprenden cepas bacterianas
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
ES2662617T3 (es) 2015-11-20 2018-04-09 4D Pharma Research Limited Composiciones que comprenden cepas bacterianas
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
CN114712405A (zh) 2016-03-04 2022-07-08 4D制药有限公司 包含细菌菌株的组合物
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
WO2017218889A1 (en) * 2016-06-16 2017-12-21 Ohio State Innovation Foundation Eubacterium probiotics and methods of treating or preventing heart disease
TW201821093A (zh) 2016-07-13 2018-06-16 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
US10653728B2 (en) 2016-10-17 2020-05-19 New York University Probiotic compositions for improving metabolism and immunity
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
RS61872B1 (sr) 2017-05-22 2021-06-30 4D Pharma Res Ltd Kompozicije koje sadrže bakterijske sojeve
JP6978514B2 (ja) 2017-05-24 2021-12-08 フォーディー ファーマ リサーチ リミテッド4D Pharma Research Limited 細菌株を含む組成物
EP3600364B1 (de) 2017-06-14 2020-08-05 4D Pharma Research Limited Zusammensetzungen mit einem bakterienstamm der gattung megasphaera und verwendungen davon
HUE052319T2 (hu) 2017-06-14 2021-04-28 4D Pharma Res Ltd Baktériumtörzseket tartalmazó készítmények
AU2018285445B2 (en) 2017-06-14 2020-03-26 Cj Bioscience, Inc. Compositions comprising bacterial strains
US11540549B2 (en) 2019-11-28 2023-01-03 Tate & Lyle Solutions Usa Llc High-fiber, low-sugar soluble dietary fibers, products including them and methods for using them

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4112222A (en) * 1977-01-07 1978-09-05 National Starch And Chemical Corp. Method of preparing hydroxypropylated starch derivatives
US5143845A (en) * 1986-09-03 1992-09-01 Toa Pharmaceutical Co., Ltd. Mixture of saccarifying lactic acid producing and butyric acid producing bacteria
DE3727946A1 (de) 1987-08-21 1989-03-02 Werner Georg Munk Rekonstituierbares trockenprodukt zum direktverzehr, verfahren zu seiner herstellung und seine verwendung
DK0885556T3 (da) * 1992-07-31 2003-01-27 Penford Holdings Pty Ltd Stivelse med højt amyloseindhold og resistente stivelsesfraktioner
US6303174B1 (en) * 1992-12-24 2001-10-16 Goodman Fielder Limited Food compositions including resistant starch
JP3559790B2 (ja) 1993-12-20 2004-09-02 松谷化学工業株式会社 食品にビフィズス菌の増殖促進作用を付与する方法
AUPM823094A0 (en) 1994-09-16 1994-10-13 Goodman Fielder Limited Probiotic compositions
JP3010007B2 (ja) 1995-05-22 2000-02-14 ビオフェルミン製薬株式会社 配合下剤

Also Published As

Publication number Publication date
EP0901371A1 (de) 1999-03-17
JP2001503016A (ja) 2001-03-06
US6348452B1 (en) 2002-02-19
CA2249189A1 (en) 1997-09-25
EP0901371A4 (de) 2004-05-12
JP4282763B2 (ja) 2009-06-24
WO1997034591A1 (en) 1997-09-25
EP0901371B1 (de) 2008-09-10
DE69738975D1 (de) 2008-10-23
US20080131401A1 (en) 2008-06-05
KR20000064729A (ko) 2000-11-06

Similar Documents

Publication Publication Date Title
ATE407700T1 (de) Veränderung der mikrobenflora im verdauungstrakt
ATE281174T1 (de) Die beschleunigung der mikrobiellen besiedlung des gastrointestinalen traktes
EP0910359A4 (de) Selektion und /oder verbesserung der mikrobiellen besiedlung des gastrointestionalen traktes
JPS5321244A (en) Construction sheet material having tenacity
MXPA01007710A (es) Agente de secado por congelacion que contiene paramilon, su produccion y uso.
ATE284922T1 (de) Zusammensetzung von nanofibrillen von cellulose mit carboxylierter cellulose mit hohem substitutionsgrad
KR970706010A (ko) 촉생 조성물(probiotic compositions)
TR199800101T1 (xx) Mod�ler damper ve bu damperle ger�ekle�tirilen yap�lar.
DE3879118D1 (de) Feuerfestes material, hergestellt aus rotschlamm.
FR2736065B1 (fr) Phosphatases alcalines bacteriennes modifiees et leurs applications.
FR2760022B1 (fr) Souche bacterienne marine du genre vibrio, polysaccharides hydrosolubles produits par cette souche, et leurs utilisations
DE59207968D1 (de) Dimeticon-pastillen
BR9609114A (pt) Composição inseticida de terra diatomácea
TR199901862T2 (xx) Yeni Bile�ikler.
KR850003434A (ko) 벼짚 톱밥을 이용한 가스없는 연료
Byrd I'm from the Country
KR910012229A (ko) 신규 유산균
Wang What accounted for the availability of higher education in Taiwan over time?
Hancox The great badgers and bovine TB debate
KR840002242A (ko) 담석증 치료약
Opp " Those who are silent have something to say"; participatory rural appraisal and the discourses of development.
RU96115796A (ru) Перевязочный материал
Brown Visit to Glendale Unified School District
RU96122435A (ru) Фрикционное изделие
Features Submission In Conclusion

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties